Signature Pharmaceuticals Limited

Signature Pharmaceuticals Limited is a popular non-government company that is well-known for its pharmaceutical products. This company was established in 1995 and is currently active.

Some of the medicines that are manufactured by this pharmaceutical company and available at Vedi Care Health are Vitara V 60 MG and Aspadol 100 mg.

Signature Pharmaceuticals Limited – A Brief Overview

Signature Pharmaceuticals is a private company that was established on 3rd February 1995. This company is classified as a ‘company limited by shares’.

The authorized capital of Signature Pharmaceuticals stands at Rs. 200.0 lakhs and has a paid-up capital of 32.4225% (64.85 lakhs).

The last AGM (annual general meeting) of this company happened on 29 September 2017, and the company last updated its financials on 31 March 2017 as per MCA (Ministry of Corporate Affairs).

Signature Pharmaceuticals has been mainly manufacturing chemicals and products for the last 29 years.

The current directors and board members are Krishnakumar Radharaman Agarwal, Sanjiv Surajbhan Garg, and Vinita Krishnakumar Agrawa.

Details about Signature Pharmaceuticals:

Some of the crucial details about Signature Pharmaceuticals are given below in the table [1].

Signature Pharmaceutics Products At Vedi Care Health

Vitara-V 60 Mg

Vitara-V 60 mg is a well-known treatment whose use is popular among men. It is used to treat impotence or erectile dysfunction in men. It helps to maintain an erection only when you’re sexually aroused within 30 minutes of administering the medicine.

The active compound present in this ED medication is Vardenafil hydrochloride.

Aspadol 100 Mg

Aspadol 100 mg is an oral medication that is approved by the U.S. Food And Drug Administration to treat chronic pain. It is an effective medication that begins to show its action within 30 minutes of taking the medicine.

Aspadol 100 mg is a round orange color tablet containing Tapentadol hydrochloride salt as the active ingredient.

Note: Tapentadol is classified as a Schedule II controlled substance (US), Schedule 8 (AU), and controlled in the UK/EU. Therefore, this medication should be used only after consulting a healthcare provider.

Nervigesic

Nervigesic, a popular brand name of Pregabalin, is an anticonvulsant (a drug used to prevent or treat seizures) and neuropathic pain medication that is prescribed for seizures (fits), management of neuropathic pain associated with spinal cord injury, fibromyalgia, diabetic peripheral neuropathy, and postherpetic neuralgia.

Nervisegic is available in the dosage strengths: Nervigesic 75 mg, Nervigesic 150 mg, and Nervigesic 300 mg.

Note: Pregabalin is classified as a Class C controlled substance in the UK (since April 2019), Schedule 4 (AU), Schedule V (US). It means Pregabalin has a lower risk of abuse potential, and should be taken only if prescribed by a doctor.